Getting a new medicine to market is a marathon, not a sprint. Or perhaps a better analogy is a steeplechase, where competitors must overcome gruelling obstacles on their way to the finish line. Clinical trials are one of the biggest hurdles on the route to market and they’re getting more
“The most successful life sciences companies will be the ones that can convince their customers – patients, health care professionals, government authorities and health plans – that new treatments are the most effective and provide true value compared with alternatives.” Jamie Powers, DrPH, Principal Consultant and Practice Lead, SAS Health
For health and life sciences organizations, discussions about big data include gaining value from that data in the form of real-world evidence. Consider for a moment the amount of healthcare data that exists today thanks to the adoption of electronic health records. Then think about the future with data from
